JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

TLRY

7.43

-0.27%↓

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

TLRY

7.43

-0.27%↓

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

TLRY

7.43

-0.27%↓

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

TLRY

7.43

-0.27%↓

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

TLRY

7.43

-0.27%↓

Search

Neogen Corp

Fechado

SetorSaúde

10.23 0.2

Visão Geral

Variação de preço das ações

24h

Atual

Mín

9.94

Máximo

10.49

Indicadores-chave

By Trading Economics

Rendimento

-52M

-16M

Vendas

16M

225M

Margem de lucro

-7.087

Funcionários

2,974

EBITDA

-66M

23M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+4.4% upside

Dividendos

By Dow Jones

Próximos Ganhos

8 de abr. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

600M

2.2B

Abertura anterior

10.03

Fecho anterior

10.23

Sentimento de Notícias

By Acuity

48%

52%

142 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Neogen Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

2 de fev. de 2026, 23:52 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2 de fev. de 2026, 23:52 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2 de fev. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2 de fev. de 2026, 23:38 UTC

Conversa de Mercado

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2 de fev. de 2026, 23:28 UTC

Conversa de Mercado

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2 de fev. de 2026, 23:23 UTC

Ganhos

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2 de fev. de 2026, 22:57 UTC

Ganhos

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 de fev. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2 de fev. de 2026, 22:08 UTC

Conversa de Mercado

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2 de fev. de 2026, 21:51 UTC

Ganhos

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

2 de fev. de 2026, 21:49 UTC

Ganhos

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2 de fev. de 2026, 21:39 UTC

Ganhos

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 de fev. de 2026, 21:36 UTC

Ganhos

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2 de fev. de 2026, 21:34 UTC

Ganhos

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 de fev. de 2026, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2 de fev. de 2026, 21:23 UTC

Ganhos

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2 de fev. de 2026, 21:19 UTC

Ganhos

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2 de fev. de 2026, 21:17 UTC

Ganhos

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2 de fev. de 2026, 21:17 UTC

Ganhos

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 de fev. de 2026, 21:10 UTC

Ganhos

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 de fev. de 2026, 21:08 UTC

Ganhos

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2 de fev. de 2026, 21:07 UTC

Ganhos

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2 de fev. de 2026, 21:05 UTC

Ganhos

Palantir Technologies 4Q Net $608.7M >PLTR

2 de fev. de 2026, 21:05 UTC

Ganhos

Palantir Technologies 4Q Rev $1.41B >PLTR

2 de fev. de 2026, 21:05 UTC

Ganhos

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2 de fev. de 2026, 21:05 UTC

Ganhos

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2 de fev. de 2026, 21:05 UTC

Ganhos

Palantir Technologies 4Q Adj EPS 25c >PLTR

2 de fev. de 2026, 21:05 UTC

Ganhos

Palantir Technologies 4Q EPS 24c >PLTR

2 de fev. de 2026, 20:40 UTC

Conversa de Mercado

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Comparação entre Pares

Variação de preço

Neogen Corp Previsão

Preço-alvo

By TipRanks

4.4% parte superior

Previsão para 12 meses

Média 10.67 USD  4.4%

Máximo 12 USD

Mínimo 10 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Neogen Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

4 ratings

2

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.17 / 5.99Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

142 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat